ConforMIS jumps on analyst ’ s upgrade
ConforMIS (NSDQ:CFMS) shares closed up more than 12% yesterday after a BTIG analyst upgraded his rating on the company, which makes customized knee and hip implants. BTIG’s Ryan Zimmerman raised his rating on CFMS shares from “neutral” to”buy,” setting a price target of $4 per share. Of the 10 analysts covering the stock, six have set “buy” ratings and four have the shares on “hold,” with price targets ranging from $28 to Zimmerman’s $4. Investors reacted to the upgrade by sending CFMS shares up 12.3% to a $2.56 close yesterday on heavy volume, after the stock peaking at $2.69. More than 1 million shares traded hands yesterday, compared with average volume of nearly 275,000 shares. Billerica, Mass.-based ConforMIS gave back some of that gain today in late-morning trading, sliding-2.7% to $2.49 per share as of about 11:15am. The stock is off -24.0% this year. The company uses computed tomography joint scans to create implants and instruments customized to each patient’s unique anatomy. ConforMIS, which paid $6.5 million for the machining and polishing assets of Broad Peak Manufacturing in August, won 510(k) clearance from the FDA for the iTotal Hip replacement system in June. The post ConforMIS jumps on analyst’s upgrade appeared first on MassDevice.
Conclusions: Proper clinical conditions, for scheduling a postextraction immediate implant placement surgery, involve the presence of 4 bone walls showing and sufficient height and width. The accurate knowledge of alveolus bone morphology of mandibular molars, prior extraction, could be an important guide to avoid potential failures due to nonideal anatomical features to fixture stabilization.
CONCLUSIONS: Using FBP, comparable IAC measurements were achieved with 91% reduction in dose compared with a standard exposure protocol. The use of ASIR and MBIR did not improve identification of the IAC in MDCT low dose images. PMID: 29791199 [PubMed - as supplied by publisher]
Iodinated contrast agents administered during computed tomography (CT) studies have the potential to cause post-contrast acute kidney injury (AKI). Prior to CT scans, in certain populations, assessment of the estimated glomerular filtration rate (eGFR) is required to identify patients at risk for adverse events after contrast administration.
Authors: Schmidt W, LiArno S, Khlopas A, Petersik A, Mont MA Abstract Due to the differences in bone morphology between demographics such as age, gender, body mass index, and ethnicity, the development of orthopaedic implants requires a large number of anatomical data from various patient populations. In an effort to assess these demographic variations, Stryker Orthopaedic Modeling and Analytics (SOMA) has been developed. SOMA is a suite of tools which utilizes a comprehensive database of computed tomography scans (CT-scans), plus associated three-dimensional (3D) bone models, allowing the user to assess population...
The aim of this systematic review is to investigate diagnostic accuracy of Magnetic Resonance Imaging (MRI) scans using liver specific tissue contrast media over contrast enhanced Multi Detector CT (MDCT) in diagnoses of Hepatocellular Carcinoma (HCC) in patients with chronic liver disease.
A 14-year-old boy presented with intermittent hematochezia for 2 weeks. He reported a similar episode of hematochezia 1 year ago that was regarded as colitis. His medical history was unremarkable. Physical examination showed a nontender, soft, palpable mass at the upper right quadrant of the abdomen. His hemoglobin level was 7.3 g/dL (normal range, 13.0–16.0 g/dL). A computed tomography scan of his abdomen showed asymmetric segmental wall thickening with scattered punctuate calcification (Figure A, white arrow) and heterogeneous enhancement from the m idtransverse colon to the hepatic flexure (Figure A, black arrow).
Conclusion Binimetinib may present a new treatment option for hormone- and chemotherapy-resistant LGSOC harboring KRAS mutations.
Conclusions—Workflow in GOLIATH demonstrates that magnetic resonance imaging selection for endovascular therapy can be accomplished rapidly and within a similar time frame as computed tomography-based selection.Clinical Trial Registration—URL: https://www.clinicaltrials.gov. Unique identifier: NCT02317237.
Background and Purpose—Clinical utility of electronic Alberta Stroke Program Early CT Score (e-ASPECTS), an automated system for quantifying signs of infarction, was evaluated in a large database of thrombolyzed patients with acute ischemic stroke.Methods—All baseline noncontrast computed tomographic scans of patients with anterior circulation acute ischemic stroke who participated in the alteplase dose arm of the randomized controlled trial ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) were reviewed; poor quality and large (>6 mm) slice thickness were excluded. Included scans ha...
Publication date: October 2018 Source:Radiation Physics and Chemistry, Volume 151 Author(s): Walmir Belinato, Rogério M.V. Silva, Ana P. Perini, Lucio P. Neves, Carla J. Santos, Divanizia N. Souza, William S. Santos In recent years, positron emission tomography (PET), associated with multi-detector computed tomography (MDCT), has become a diagnostic technique widely disseminated to evaluate various malignant tumors and other diseases. However, during PET/CT examinations, the doses of ionizing radiation experienced by the internal organs of the patients due to 18F are unknown, and may be substantial. The aim of this...